Kenvue Doesn’t ‘See Consumers Downgrading’ As Analysts See US Private Label Sales Growing

“We have a relatively low exposure to private label to start with. But we don't see penetration of private label going up in 2024,” says CEO Thibaut Mongon. Recent research from analysts, though, shows increase in consumers turning to lower-priced health and personal care alternatives.

Losing consumer health product market share to private label isn’t appearing on Kenvue Inc.’s radar even though market analysts say consumers are “being squeezed” and Kenvue and its competitors should consider lowering their prices.

“We have a relatively low exposure to private label to start with. But we don't see penetration of private label...